{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T05:52:24Z","timestamp":1792129944304,"version":"4.4.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Health@InnoHK Initiative Fund","award":["ITC RC\/IHK\/4\/7"],"award-info":[{"award-number":["ITC RC\/IHK\/4\/7"]}]},{"name":"Health@InnoHK Initiative Fund","award":["ITC RC\/IHK\/4\/7"],"award-info":[{"award-number":["ITC RC\/IHK\/4\/7"]}]},{"name":"Health@InnoHK Initiative Fund","award":["ITC RC\/IHK\/4\/7"],"award-info":[{"award-number":["ITC RC\/IHK\/4\/7"]}]},{"name":"Health@InnoHK Initiative Fund","award":["ITC RC\/IHK\/4\/7"],"award-info":[{"award-number":["ITC RC\/IHK\/4\/7"]}]},{"name":"Health@InnoHK Initiative Fund","award":["ITC RC\/IHK\/4\/7"],"award-info":[{"award-number":["ITC RC\/IHK\/4\/7"]}]},{"name":"Vincent and Lily Woo Foundation"},{"DOI":"10.13039\/501100001747","name":"Hong Kong Baptist University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001747","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Abdominal pain in constipation-predominant irritable bowel syndrome (IBS-C) and functional constipation (FC) remains a difficult clinical challenge due to unclear pathophysiological mechanisms and limited pain-targeted treatments. This review critically evaluates the evidence on the underlying pain mechanisms in IBS-C and\/or FC and explores management strategies, their limitations, and future directions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Most research on constipation-related pain is based on IBS-C patients or animal models, with limited studies focusing on FC. Visceral hypersensitivity, serotonin dysregulation, gut-brain axis dysfunction, and central\/peripheral nervous system alterations are implicated in IBS-C pain, while FC pain is less studied and may be primarily linked to colonic distension and motility dysfunction. Management strategies include 5-HT4 agonists, GC-C agonists, chloride channel activators, psychological therapies, probiotics and complementary medicine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Despite available treatment options, managing abdominal pain in IBS-C and FC remains challenging due to heterogeneous pathophysiology and limited targeted therapies. While some interventions provide symptomatic relief, there is no universally effective treatment for abdominal pain across all patients. Future research should focus on identifying pain-specific biomarkers, refining diagnostic criteria, and integrating multi-omics data and neuroimaging techniques to better distinguish pain mechanisms in IBS-C versus FC and develop more precise, patient-centered interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11894-025-00967-7","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T07:47:23Z","timestamp":1742197643000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Decoding Abdominal Pain in Constipation-predominant Irritable Bowel Syndrome and Functional Constipation: Mechanisms and Managements"],"prefix":"10.1007","volume":"27","author":[{"given":"Jingyuan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiang","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Su","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6206-1958","authenticated-orcid":false,"given":"Zhaoxiang","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"issue":"5","key":"967_CR1","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1053\/j.gastro.2019.12.034","volume":"158","author":"AE Bharucha","year":"2020","unstructured":"Bharucha AE, Lacy BE. Mechanisms, evaluation, and management of chronic constipation. Gastroenterology. 2020;158(5):1232-49.e3. https:\/\/doi.org\/10.1053\/j.gastro.2019.12.034.","journal-title":"Gastroenterology"},{"issue":"1","key":"967_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","volume":"160","author":"AD Sperber","year":"2021","unstructured":"Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of rome foundation global study. Gastroenterology. 2021;160(1):99-114.e3. https:\/\/doi.org\/10.1053\/j.gastro.2020.04.014.","journal-title":"Gastroenterology"},{"issue":"1","key":"967_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpg.2010.12.010","volume":"25","author":"SM Mugie","year":"2011","unstructured":"Mugie SM, Benninga MA, Di Lorenzo C. Epidemiology of constipation in children and adults: a systematic review. Best Pract Res Clin Gastroenterol. 2011;25(1):3\u201318. https:\/\/doi.org\/10.1016\/j.bpg.2010.12.010.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"1","key":"967_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1053\/j.gastro.2018.08.063","volume":"156","author":"AF Peery","year":"2019","unstructured":"Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: Update 2018. Gastroenterology. 2019;156(1):254-72.e11. https:\/\/doi.org\/10.1053\/j.gastro.2018.08.063.","journal-title":"Gastroenterology"},{"key":"967_CR5","doi-asserted-by":"publisher","unstructured":"Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterology. 2016. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.031.","DOI":"10.1053\/j.gastro.2016.02.031."},{"issue":"6","key":"967_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.17235\/reed.2016.4389\/2016","volume":"108","author":"F Mearin","year":"2016","unstructured":"Mearin F, Ciriza C, M\u00ednguez M, Rey E, Mascort JJ, Pe\u00f1a E, et al. Clinical practice guideline: Irritable bowel syndrome with constipation and functional constipation in the adult. Rev Esp Enferm Dig. 2016;108(6):332\u201363. https:\/\/doi.org\/10.17235\/reed.2016.4389\/2016.","journal-title":"Rev Esp Enferm Dig"},{"issue":"1","key":"967_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.14309\/ajg.0000000000000816","volume":"116","author":"JK Ruffle","year":"2021","unstructured":"Ruffle JK, Tinkler L, Emmett C, Ford AC, Nachev P, Aziz Q, et al. Constipation predominant irritable bowel syndrome and functional constipation are not discrete disorders: A machine learning approach. Am J Gastroenterol. 2021;116(1):142\u201351. https:\/\/doi.org\/10.14309\/ajg.0000000000000816.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"967_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/ajg.2010.305","volume":"106","author":"CW Cheng","year":"2011","unstructured":"Cheng CW, Bian ZX, Zhu LX, Wu JC, Sung JJ. Efficacy of a Chinese herbal proprietary medicine (Hemp Seed Pill) for functional constipation. Am J Gastroenterol. 2011;106(1):120\u20139. https:\/\/doi.org\/10.1038\/ajg.2010.305.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"967_CR9","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.cgh.2018.04.005","volume":"17","author":"L Zhong","year":"2018","unstructured":"Zhong L, Cheng C-W, Kun W, Dai L, Hu D-d, Ning Z-w, et al. Efficacy of MaZiRenWan, a Chinese herbal medicine, in patients with functional constipation in a randomized controlled trial. Clin Gastroenterol Hepatol. 2018;17(7):1303-1310.e18. https:\/\/doi.org\/10.1016\/j.cgh.2018.04.005.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"967_CR10","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1038\/ajg.2010.200","volume":"105","author":"RK Wong","year":"2010","unstructured":"Wong RK, Palsson OS, Turner MJ, Levy RL, Feld AD, von Korff M, et al. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome. Am J Gastroenterol. 2010;105(10):2228\u201334. https:\/\/doi.org\/10.1038\/ajg.2010.200.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"967_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1053\/j.gastro.2013.07.014","volume":"145","author":"C Shekhar","year":"2013","unstructured":"Shekhar C, Monaghan PJ, Morris J, Issa B, Whorwell PJ, Keevil B, et al. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin. Gastroenterology. 2013;145(4):749\u201357. https:\/\/doi.org\/10.1053\/j.gastro.2013.07.014.","journal-title":"Gastroenterology"},{"issue":"6","key":"967_CR12","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/ajg.2014.18","volume":"109","author":"E Rey","year":"2014","unstructured":"Rey E, Balboa A, Mearin F. Chronic constipation, irritable bowel syndrome with constipation and constipation with pain\/discomfort: similarities and differences. Am J Gastroenterol. 2014;109(6):876\u201384. https:\/\/doi.org\/10.1038\/ajg.2014.18.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"967_CR13","first-page":"171","volume":"12","author":"KT Siah","year":"2016","unstructured":"Siah KT, Wong RK, Whitehead WE. Chronic constipation and constipation-predominant IBS: separate and distinct disorders or a spectrum of disease? Gastroenterol Hepatol (N Y). 2016;12(3):171\u20138.","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"7","key":"967_CR14","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s10620-018-5027-2","volume":"63","author":"AE Bharucha","year":"2018","unstructured":"Bharucha AE, Sharma M. Painful and painless constipation: All roads lead to (A change in) Rome. Dig Dis Sci. 2018;63(7):1671\u20134. https:\/\/doi.org\/10.1007\/s10620-018-5027-2.","journal-title":"Dig Dis Sci"},{"issue":"7","key":"967_CR15","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s10620-018-4995-6","volume":"63","author":"M Bouchoucha","year":"2018","unstructured":"Bouchoucha M, Devroede G, Mary F, Bon C, Bejou B, Benamouzig R. Painful or mild-pain constipation? a clinically useful alternative to classification as irritable bowel syndrome with constipation versus functional constipation. Dig Dis Sci. 2018;63(7):1763\u201373. https:\/\/doi.org\/10.1007\/s10620-018-4995-6.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"967_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41572-020-00222-5","volume":"6","author":"N Thapar","year":"2020","unstructured":"Thapar N, Benninga MA, Crowell MD, Di Lorenzo C, Mack I, Nurko S, et al. Paediatric functional abdominal pain disorders. Nat Rev Dis Primers. 2020;6(1):89. https:\/\/doi.org\/10.1038\/s41572-020-00222-5.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"967_CR17","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1111\/jgh.14970","volume":"35","author":"MYW Wong","year":"2020","unstructured":"Wong MYW, Hebbard G, Gibson PR, Burgell RE. Chronic constipation and abdominal pain: Independent or closely interrelated symptoms? J Gastroenterol Hepatol. 2020;35(8):1294\u2013301. https:\/\/doi.org\/10.1111\/jgh.14970.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"967_CR18","doi-asserted-by":"publisher","first-page":"e13729","DOI":"10.1111\/nmo.13729","volume":"32","author":"Z Mujagic","year":"2020","unstructured":"Mujagic Z, Weerts Z, Vork L, Leue C, Kruimel JW, Hesselink M, et al. Quality of life in irritable bowel syndrome: Authors\u2019 reply. Neurogastroenterol Motil. 2020;32(1):e13729. https:\/\/doi.org\/10.1111\/nmo.13729.","journal-title":"Neurogastroenterol Motil"},{"key":"967_CR19","doi-asserted-by":"publisher","first-page":"S229","DOI":"10.14309\/01.ajg.0000774524.77992.13","volume":"116","author":"BE Lacy","year":"2021","unstructured":"Lacy BE, Parikh M, Taylor DCA, Bloudek LM, Burslem K, Morlock A, et al. S512 Prevalence and impact of abdominal symptoms in patients with IBS-C. Am J Gastroenterol. 2021;116:S229\u201330.","journal-title":"Am J Gastroenterol"},{"key":"967_CR20","doi-asserted-by":"publisher","first-page":"S457","DOI":"10.14309\/01.ajg.0000952132.11568.3d","volume":"118","author":"KJ Kosch","year":"2023","unstructured":"Kosch KJ, Ye X, Xu Y, McKnight-Smith G, Ando M, Dobrescu R, et al. S623 Treatment satisfaction and quality of life in patients with irritable bowel syndrome with constipation and chronic idiopathic constipation. Am J Gastroenterol. 2023;118:S457\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"967_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1572-0241.2006.00404.x","volume":"101","author":"KC Cain","year":"2006","unstructured":"Cain KC, Headstrom P, Jarrett ME, Motzer SA, Park H, Burr RL, et al. Abdominal pain impacts quality of life in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101(1):124\u201332. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00404.x.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"967_CR22","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1136\/gutjnl-2011-301181","volume":"61","author":"S Nullens","year":"2012","unstructured":"Nullens S, Nelsen T, Camilleri M, Burton D, Eckert D, Iturrino J, et al. Regional colon transit in patients with dys-synergic defaecation or slow transit in patients with constipation. Gut. 2012;61(8):1132\u20139. https:\/\/doi.org\/10.1136\/gutjnl-2011-301181.","journal-title":"Gut"},{"issue":"2","key":"967_CR23","doi-asserted-by":"publisher","first-page":"196","DOI":"10.5009\/gnl16126","volume":"11","author":"UC Ghoshal","year":"2017","unstructured":"Ghoshal UC, Shukla R, Ghoshal U. Small intestinal bacterial overgrowth and irritable bowel syndrome: a bridge between functional organic dichotomy. Gut Liver. 2017;11(2):196\u2013208. https:\/\/doi.org\/10.5009\/gnl16126.","journal-title":"Gut Liver"},{"issue":"24","key":"967_CR24","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.3748\/wjg.v16.i24.2978","volume":"16","author":"J Bures","year":"2010","unstructured":"Bures J, Cyrany J, Kohoutova D, F\u00f6rstl M, Rejchrt S, Kvetina J, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010;16(24):2978\u201390. https:\/\/doi.org\/10.3748\/wjg.v16.i24.2978.","journal-title":"World J Gastroenterol"},{"issue":"21","key":"967_CR25","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.3748\/wjg.v23.i21.3771","volume":"23","author":"A Cozma-Petru\u0163","year":"2017","unstructured":"Cozma-Petru\u0163 A, Loghin F, Miere D, Dumitra\u015fcu DL. Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients! World J Gastroenterol. 2017;23(21):3771\u201383. https:\/\/doi.org\/10.3748\/wjg.v23.i21.3771.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"967_CR26","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/jhn.12385","volume":"29","author":"YA McKenzie","year":"2016","unstructured":"McKenzie YA, Bowyer RK, Leach H, Gulia P, Horobin J, O\u2019Sullivan NA, et al. British dietetic association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet. 2016;29(5):549\u201375. https:\/\/doi.org\/10.1111\/jhn.12385.","journal-title":"J Hum Nutr Diet"},{"issue":"5","key":"967_CR27","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1365-2982.2011.01872.x","volume":"24","author":"H Miwa","year":"2012","unstructured":"Miwa H. Life style in persons with functional gastrointestinal disorders\u2013large-scale internet survey of lifestyle in Japan. Neurogastroenterol Motil. 2012;24(5):464-71,e217. https:\/\/doi.org\/10.1111\/j.1365-2982.2011.01872.x.","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"967_CR28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.5009\/gnl13437","volume":"9","author":"YB Guo","year":"2015","unstructured":"Guo YB, Zhuang KM, Kuang L, Zhan Q, Wang XF, Liu SD. Association between diet and lifestyle habits and irritable bowel syndrome: a case-control study. Gut Liver. 2015;9(5):649\u201356. https:\/\/doi.org\/10.5009\/gnl13437.","journal-title":"Gut Liver"},{"issue":"3","key":"967_CR29","first-page":"387","volume":"89","author":"MD Crowell","year":"1994","unstructured":"Crowell MD, Cheskin LJ, Musial F. Prevalence of gastrointestinal symptoms in obese and normal weight binge eaters. Am J Gastroenterol. 1994;89(3):387\u201391.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"967_CR30","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/ajg.2013.105","volume":"108","author":"L B\u00f6hn","year":"2013","unstructured":"B\u00f6hn L, St\u00f6rsrud S, T\u00f6rnblom H, Bengtsson U, Simr\u00e9n M. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol. 2013;108(5):634\u201341. https:\/\/doi.org\/10.1038\/ajg.2013.105.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"967_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.5056\/jnm.2010.16.2.131","volume":"16","author":"S Gonlachanvit","year":"2010","unstructured":"Gonlachanvit S. Are rice and spicy diet good for functional gastrointestinal disorders? J Neurogastroenterol Motil. 2010;16(2):131\u20138. https:\/\/doi.org\/10.5056\/jnm.2010.16.2.131.","journal-title":"J Neurogastroenterol Motil"},{"issue":"7","key":"967_CR32","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/gut.2007.138982","volume":"57","author":"A Akbar","year":"2008","unstructured":"Akbar A, Yiangou Y, Facer P, Walters JR, Anand P, Ghosh S. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut. 2008;57(7):923\u20139. https:\/\/doi.org\/10.1136\/gut.2007.138982.","journal-title":"Gut"},{"issue":"5","key":"967_CR33","first-page":"179","volume":"21","author":"MK Agarwal","year":"2002","unstructured":"Agarwal MK, Bhatia SJ, Desai SA, Bhure U, Melgiri S. Effect of red chillies on small bowel and colonic transit and rectal sensitivity in men with irritable bowel syndrome. Indian J Gastroenterol. 2002;21(5):179\u201382.","journal-title":"Indian J Gastroenterol"},{"issue":"2","key":"967_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1572-0241.2005.40100.x","volume":"100","author":"MP Caldarella","year":"2005","unstructured":"Caldarella MP, Milano A, Laterza F, Sacco F, Balatsinou C, Lapenna D, et al. Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion. Am J Gastroenterol. 2005;100(2):383\u20139. https:\/\/doi.org\/10.1111\/j.1572-0241.2005.40100.x.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"967_CR35","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/ajg.2014.195","volume":"109","author":"P Moayyedi","year":"2014","unstructured":"Moayyedi P, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, et al. The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109(9):1367\u201374. https:\/\/doi.org\/10.1038\/ajg.2014.195.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"967_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/nt.0000000000000082","volume":"50","author":"JW McRorie Jr","year":"2015","unstructured":"McRorie JW Jr. Evidence-based approach to fiber supplements and clinically meaningful health benefits, part 1: what to look for and how to recommend an effective fiber therapy. Nutr Today. 2015;50(2):82\u20139. https:\/\/doi.org\/10.1097\/nt.0000000000000082.","journal-title":"Nutr Today"},{"issue":"7","key":"967_CR37","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1586\/17474124.2014.917956","volume":"8","author":"CJ Tuck","year":"2014","unstructured":"Tuck CJ, Muir JG, Barrett JS, Gibson PR. Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2014;8(7):819\u201334. https:\/\/doi.org\/10.1586\/17474124.2014.917956.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"967_CR38","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1053\/j.gastro.2015.02.005","volume":"148","author":"PR Gibson","year":"2015","unstructured":"Gibson PR, Varney J, Malakar S, Muir JG. Food components and irritable bowel syndrome. Gastroenterology. 2015;148(6):1158-74.e4. https:\/\/doi.org\/10.1053\/j.gastro.2015.02.005.","journal-title":"Gastroenterology"},{"key":"967_CR39","doi-asserted-by":"publisher","unstructured":"Aguilera-Lizarraga J, Florens MV, Viola MF, Jain P, Decraecker L, Appeltans I, et al. Local immune response to food antigens drives meal-induced abdominal pain. Nature. 2021. https:\/\/doi.org\/10.1038\/s41586-020-03118-2.","DOI":"10.1038\/s41586-020-03118-2"},{"key":"967_CR40","doi-asserted-by":"publisher","unstructured":"Singh P, Grabauskas G, Zhou SY, Gao J, Zhang Y, Owyang C. High FODMAP diet causes barrier loss via lipopolysaccharidemediated mast cell activation. JCI insight. 2021;6(22):e146529. https:\/\/doi.org\/10.1172\/jci.insight.146529.","DOI":"10.1172\/jci.insight.146529"},{"issue":"6","key":"967_CR41","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.cell.2020.08.007","volume":"182","author":"RAT Mars","year":"2020","unstructured":"Mars RAT, Yang Y, Ward T, Houtti M, Priya S, Lekatz HR, et al. Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable bowel syndrome. Cell. 2020;182(6):1460-73.e17. https:\/\/doi.org\/10.1016\/j.cell.2020.08.007.","journal-title":"Cell"},{"issue":"1","key":"967_CR42","doi-asserted-by":"publisher","first-page":"10322","DOI":"10.1038\/s41598-017-10835-8","volume":"7","author":"H Cao","year":"2017","unstructured":"Cao H, Liu X, An Y, Zhou G, Liu Y, Xu M, et al. Dysbiosis contributes to chronic constipation development via regulation of serotonin transporter in the intestine. Sci Rep. 2017;7(1):10322. https:\/\/doi.org\/10.1038\/s41598-017-10835-8.","journal-title":"Sci Rep"},{"issue":"2","key":"967_CR43","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.10.005","volume":"150","author":"G Parthasarathy","year":"2016","unstructured":"Parthasarathy G, Chen J, Chen X, Chia N, O\u2019Connor HM, Wolf PG, et al. Relationship between microbiota of the colonic mucosa vs feces and symptoms, colonic transit, and methane production in female patients with chronic constipation. Gastroenterology. 2016;150(2):367-79.e1. https:\/\/doi.org\/10.1053\/j.gastro.2015.10.005.","journal-title":"Gastroenterology"},{"key":"967_CR44","doi-asserted-by":"publisher","unstructured":"Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. Lancet. 2020. https:\/\/doi.org\/10.1016\/s0140-6736(20)31548-8.","DOI":"10.1016\/s0140-6736(20)31548-8"},{"issue":"2","key":"967_CR45","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1053\/j.gastro.2015.12.023","volume":"150","author":"EM Quigley","year":"2016","unstructured":"Quigley EM, Spiller RC. Constipation and the microbiome: lumen versus mucosa! Gastroenterology. 2016;150(2):300\u20133. https:\/\/doi.org\/10.1053\/j.gastro.2015.12.023.","journal-title":"Gastroenterology"},{"key":"967_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fmed.2019.00019","volume":"6","author":"T Ohkusa","year":"2019","unstructured":"Ohkusa T, Koido S, Nishikawa Y, Sato N. Gut microbiota and chronic constipation: a review and update. Front Med (Lausanne). 2019;6:19. https:\/\/doi.org\/10.3389\/fmed.2019.00019.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"967_CR47","first-page":"203","volume":"28","author":"M Carabotti","year":"2015","unstructured":"Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28(2):203\u20139.","journal-title":"Ann Gastroenterol"},{"issue":"4","key":"967_CR48","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1111\/nmo.12103","volume":"25","author":"L Crouzet","year":"2013","unstructured":"Crouzet L, Gaultier E, Del\u2019Homme C, Cartier C, Delmas E, Dapoigny M, et al. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterol Motil. 2013;25(4):e272\u201382. https:\/\/doi.org\/10.1111\/nmo.12103.","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"967_CR49","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1136\/gut.2005.066100","volume":"55","author":"EF Verd\u00fa","year":"2006","unstructured":"Verd\u00fa EF, Bercik P, Verma-Gandhu M, Huang XX, Blennerhassett P, Jackson W, et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut. 2006;55(2):182\u201390. https:\/\/doi.org\/10.1136\/gut.2005.066100.","journal-title":"Gut"},{"issue":"1","key":"967_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nm1521","volume":"13","author":"C Rousseaux","year":"2007","unstructured":"Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med. 2007;13(1):35\u20137. https:\/\/doi.org\/10.1038\/nm1521.","journal-title":"Nat Med"},{"issue":"30","key":"967_CR51","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.3748\/wjg.v18.i30.4012","volume":"18","author":"P Ducrott\u00e9","year":"2012","unstructured":"Ducrott\u00e9 P, Sawant P, Jayanthi V. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World J Gastroenterol. 2012;18(30):4012\u20138. https:\/\/doi.org\/10.3748\/wjg.v18.i30.4012.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"967_CR52","doi-asserted-by":"publisher","first-page":"e1445","DOI":"10.1542\/peds.2010-0467","volume":"126","author":"R Francavilla","year":"2010","unstructured":"Francavilla R, Miniello V, Magist\u00e0 AM, De Canio A, Bucci N, Gagliardi F, et al. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics. 2010;126(6):e1445\u201352. https:\/\/doi.org\/10.1542\/peds.2010-0467.","journal-title":"Pediatrics"},{"issue":"7","key":"967_CR53","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.3748\/wjg.v22.i7.2242","volume":"22","author":"E Sinagra","year":"2016","unstructured":"Sinagra E, Pompei G, Tomasello G, Cappello F, Morreale GC, Amvrosiadis G, et al. Inflammation in irritable bowel syndrome: Myth or new treatment target? World J Gastroenterol. 2016;22(7):2242\u201355. https:\/\/doi.org\/10.3748\/wjg.v22.i7.2242.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"967_CR54","doi-asserted-by":"publisher","first-page":"69","DOI":"10.15171\/mejdd.2019.130","volume":"11","author":"A Sadeghi","year":"2019","unstructured":"Sadeghi A, Biglari M, Nasseri MS. Post-infectious Irritable Bowel Syndrome: A Narrative Review. Middle East J Dig Dis. 2019;11(2):69\u201375. https:\/\/doi.org\/10.15171\/mejdd.2019.130.","journal-title":"Middle East J Dig Dis"},{"key":"967_CR55","doi-asserted-by":"publisher","unstructured":"Hughes PA, Harrington AM, Castro J, Liebregts T, Adam B, Grasby DJ, et al. Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes. Gut. 2013;62(10):1456\u201365. https:\/\/doi.org\/10.1136\/gutjnl-2011-301856.","DOI":"10.1136\/gutjnl-2011-301856"},{"issue":"7","key":"967_CR56","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.burns.2012.05.024","volume":"38","author":"AD Widgerow","year":"2012","unstructured":"Widgerow AD, Kalaria S. Pain mediators and wound healing\u2013establishing the connection. Burns. 2012;38(7):951\u20139. https:\/\/doi.org\/10.1016\/j.burns.2012.05.024.","journal-title":"Burns"},{"issue":"655","key":"967_CR57","doi-asserted-by":"publisher","first-page":"eabj1895","DOI":"10.1126\/scitranslmed.abj1895","volume":"14","author":"G De Palma","year":"2022","unstructured":"De Palma G, Shimbori C, Reed DE, Yu Y, Rabbia V, Lu J, et al. Histamine production by the gut microbiota induces visceral hyperalgesia through histamine 4 receptor signaling in mice. Sci Transl Med. 2022;14(655):eabj1895. https:\/\/doi.org\/10.1126\/scitranslmed.abj1895.","journal-title":"Sci Transl Med"},{"issue":"4","key":"967_CR58","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1152\/physrev.00054.2017","volume":"98","author":"P Hegyi","year":"2018","unstructured":"Hegyi P, Mal\u00e9th J, Walters JR, Hofmann AF, Keely SJ. Guts and gall: bile acids in regulation of intestinal epithelial function in health and disease. Physiol Rev. 2018;98(4):1983\u20132023. https:\/\/doi.org\/10.1152\/physrev.00054.2017.","journal-title":"Physiol Rev"},{"issue":"2","key":"967_CR59","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1053\/j.gastro.2015.04.011","volume":"149","author":"N Cenac","year":"2015","unstructured":"Cenac N, Bautzova T, Le Faouder P, Veldhuis NA, Poole DP, Rolland C, et al. Quantification and potential functions of endogenous agonists of transient receptor potential channels in patients with irritable bowel syndrome. Gastroenterology. 2015;149(2):433-44.e7. https:\/\/doi.org\/10.1053\/j.gastro.2015.04.011.","journal-title":"Gastroenterology"},{"issue":"5","key":"967_CR60","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1053\/j.gastro.2020.10.066","volume":"160","author":"KG Margolis","year":"2021","unstructured":"Margolis KG, Cryan JF, Mayer EA. The microbiota-gut-brain axis: from motility to mood. Gastroenterology. 2021;160(5):1486\u2013501. https:\/\/doi.org\/10.1053\/j.gastro.2020.10.066.","journal-title":"Gastroenterology"},{"issue":"1","key":"967_CR61","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","volume":"132","author":"MD Gershon","year":"2007","unstructured":"Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007;132(1):397\u2013414. https:\/\/doi.org\/10.1053\/j.gastro.2006.11.002.","journal-title":"Gastroenterology"},{"issue":"23","key":"967_CR62","doi-asserted-by":"publisher","first-page":"13525","DOI":"10.1073\/pnas.2233056100","volume":"100","author":"F C\u00f4t\u00e9","year":"2003","unstructured":"C\u00f4t\u00e9 F, Th\u00e9venot E, Fligny C, Fromes Y, Darmon M, Ripoche MA, et al. Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proc Natl Acad Sci U S A. 2003;100(23):13525\u201330. https:\/\/doi.org\/10.1073\/pnas.2233056100.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"967_CR63","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1365-2885.2008.00944.x","volume":"31","author":"LF Mohammad-Zadeh","year":"2008","unstructured":"Mohammad-Zadeh LF, Moses L, Gwaltney-Brant SM. Serotonin: a review. J Vet Pharmacol Ther. 2008;31(3):187\u201399. https:\/\/doi.org\/10.1111\/j.1365-2885.2008.00944.x.","journal-title":"J Vet Pharmacol Ther"},{"issue":"2","key":"967_CR64","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","volume":"161","author":"JM Yano","year":"2015","unstructured":"Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161(2):264\u201376. https:\/\/doi.org\/10.1016\/j.cell.2015.02.047.","journal-title":"Cell"},{"issue":"11","key":"967_CR65","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1046\/j.1365-2036.2003.01591.x","volume":"17","author":"JS Kalantar","year":"2003","unstructured":"Kalantar JS, Locke GR 3rd, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ 3rd. Is irritable bowel syndrome more likely to be persistent in those with relatives who suffer from gastrointestinal symptoms? A population-based study at three time points. Aliment Pharmacol Ther. 2003;17(11):1389\u201397. https:\/\/doi.org\/10.1046\/j.1365-2036.2003.01591.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"967_CR66","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cgh.2006.10.009","volume":"5","author":"AO Chan","year":"2007","unstructured":"Chan AO, Lam KF, Hui WM, Leung G, Wong NY, Lam SK, et al. Influence of positive family history on clinical characteristics of functional constipation. Clin Gastroenterol Hepatol. 2007;5(2):197\u2013200. https:\/\/doi.org\/10.1016\/j.cgh.2006.10.009.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"967_CR67","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/MPG.0b013e3181a0a595","volume":"50","author":"W Ostwani","year":"2010","unstructured":"Ostwani W, Dolan J, Elitsur Y. Familial clustering of habitual constipation: a prospective study in children from West Virginia. J Pediatr Gastroenterol Nutr. 2010;50(3):287\u20139. https:\/\/doi.org\/10.1097\/MPG.0b013e3181a0a595.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"967_CR68","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3389\/fpsyt.2020.00805","volume":"11","author":"S Mahurkar-Joshi","year":"2020","unstructured":"Mahurkar-Joshi S, Chang L. Epigenetic mechanisms in irritable bowel syndrome. Front Psychiatry. 2020;11:805. https:\/\/doi.org\/10.3389\/fpsyt.2020.00805.","journal-title":"Front Psychiatry"},{"issue":"7","key":"967_CR69","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10151-013-1106-8","volume":"18","author":"C Stasi","year":"2014","unstructured":"Stasi C, Bellini M, Bassotti G, Blandizzi C, Milani S. Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome. Tech Coloproctol. 2014;18(7):613\u201321. https:\/\/doi.org\/10.1007\/s10151-013-1106-8.","journal-title":"Tech Coloproctol"},{"issue":"9","key":"967_CR70","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1111\/jgh.13296","volume":"31","author":"LT Hsu","year":"2016","unstructured":"Hsu LT, Hung KY, Wu HW, Liu WW, She MP, Lee TC, et al. Gut-derived cholecystokinin contributes to visceral hypersensitivity via nerve growth factor-dependent neurite outgrowth. J Gastroenterol Hepatol. 2016;31(9):1594\u2013603. https:\/\/doi.org\/10.1111\/jgh.13296.","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"967_CR71","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.neuropharm.2005.08.004","volume":"49","author":"W Gaida","year":"2005","unstructured":"Gaida W, Klinder K, Arndt K, Weiser T. Ambroxol, a Nav1.8-preferring Na(+) channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain. Neuropharmacology. 2005;49(8):1220\u20137. https:\/\/doi.org\/10.1016\/j.neuropharm.2005.08.004.","journal-title":"Neuropharmacology"},{"issue":"3","key":"967_CR72","doi-asserted-by":"publisher","first-page":"e18035","DOI":"10.1371\/journal.pone.0018035","volume":"6","author":"P Karling","year":"2011","unstructured":"Karling P, Danielsson \u00c5, Wikgren M, S\u00f6derstr\u00f6m I, Del-Favero J, Adolfsson R, et al. The relationship between the val158met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome. PLoS ONE. 2011;6(3):e18035. https:\/\/doi.org\/10.1371\/journal.pone.0018035.","journal-title":"PLoS ONE"},{"issue":"2","key":"967_CR73","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.bmcl.2014.11.062","volume":"25","author":"Y Iwata","year":"2015","unstructured":"Iwata Y, Ando K, Taniguchi K, Koba N, Sugiura A, Sudo M. Identification of a highly potent and selective CB2 agonist, RQ-00202730, for the treatment of irritable bowel syndrome. Bioorg Med Chem Lett. 2015;25(2):236\u201340. https:\/\/doi.org\/10.1016\/j.bmcl.2014.11.062.","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"967_CR74","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.bbrc.2015.11.102","volume":"469","author":"XJ Liao","year":"2016","unstructured":"Liao XJ, Mao WM, Wang Q, Yang GG, Wu WJ, Shao SX. MicroRNA-24 inhibits serotonin reuptake transporter expression and aggravates irritable bowel syndrome. Biochem Biophys Res Commun. 2016;469(2):288\u201393. https:\/\/doi.org\/10.1016\/j.bbrc.2015.11.102.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"967_CR75","doi-asserted-by":"publisher","first-page":"14680","DOI":"10.1038\/s41598-017-13982-0","volume":"7","author":"C Wohlfarth","year":"2017","unstructured":"Wohlfarth C, Schmitteckert S, H\u00e4rtle JD, Houghton LA, Dweep H, Fortea M, et al. miR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in irritable bowel syndrome. Sci Rep. 2017;7(1):14680. https:\/\/doi.org\/10.1038\/s41598-017-13982-0.","journal-title":"Sci Rep"},{"issue":"6","key":"967_CR76","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1586\/17474124.2014.911659","volume":"8","author":"YM Chang","year":"2014","unstructured":"Chang YM, El-Zaatari M, Kao JY. Does stress induce bowel dysfunction? Expert Rev Gastroenterol Hepatol. 2014;8(6):583\u20135. https:\/\/doi.org\/10.1586\/17474124.2014.911659.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"967_CR77","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.expneurol.2011.04.020","volume":"233","author":"M Larauche","year":"2012","unstructured":"Larauche M, Mulak A, Tach\u00e9 Y. Stress and visceral pain: from animal models to clinical therapies. Exp Neurol. 2012;233(1):49\u201367. https:\/\/doi.org\/10.1016\/j.expneurol.2011.04.020.","journal-title":"Exp Neurol"},{"issue":"3","key":"967_CR78","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/bf03343838","volume":"24","author":"FR Patacchioli","year":"2001","unstructured":"Patacchioli FR, Angelucci L, Dellerba G, Monnazzi P, Leri O. Actual stress, psychopathology and salivary cortisol levels in the irritable bowel syndrome (IBS). J Endocrinol Invest. 2001;24(3):173\u20137. https:\/\/doi.org\/10.1007\/bf03343838.","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"967_CR79","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/0016-5085(89)91678-8","volume":"97","author":"M Gu\u00e9","year":"1989","unstructured":"Gu\u00e9 M, Peeters T, Depoortere I, Vantrappen G, Bu\u00e9no L. Stress-induced changes in gastric emptying, postprandial motility, and plasma gut hormone levels in dogs. Gastroenterology. 1989;97(5):1101\u20137. https:\/\/doi.org\/10.1016\/0016-5085(89)91678-8.","journal-title":"Gastroenterology"},{"issue":"4","key":"967_CR80","doi-asserted-by":"publisher","first-page":"964","DOI":"10.5555\/uri:pii:001650859190270U","volume":"100","author":"M Gue","year":"1991","unstructured":"Gue M, Junien JL, Bueno L. Conditioned emotional response in rats enhances colonic motility through the central release of corticotropin-releasing factor. Gastroenterology. 1991;100(4):964\u201370. https:\/\/doi.org\/10.5555\/uri:pii:001650859190270U.","journal-title":"Gastroenterology"},{"key":"967_CR81","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev.physiol.010908.163221","volume":"71","author":"A Stengel","year":"2009","unstructured":"Stengel A, Tach\u00e9 Y. Neuroendocrine control of the gut during stress: corticotropin-releasing factor signaling pathways in the spotlight. Annu Rev Physiol. 2009;71:219\u201339. https:\/\/doi.org\/10.1146\/annurev.physiol.010908.163221.","journal-title":"Annu Rev Physiol"},{"issue":"10","key":"967_CR82","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1111\/nmo.13877","volume":"32","author":"QQ Luo","year":"2020","unstructured":"Luo QQ, Wang B, Chen X, Qiu HY, Li WT, Yan XJ, et al. Acute stress induces visceral hypersensitivity via glucocorticoid receptor-mediated membrane insertion of TRPM8: Involvement of a non-receptor tyrosine kinase Pyk2. Neurogastroenterol Motil. 2020;32(10):1514\u201328. https:\/\/doi.org\/10.1111\/nmo.13877.","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"967_CR83","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/17474124.2020.1708718","volume":"14","author":"I Aziz","year":"2020","unstructured":"Aziz I, Whitehead WE, Palsson OS, Tornblom H, Simren M. An approach to the diagnosis and management of Rome IV functional disorders of chronic constipation. Expert Rev Gastroenterol Hepatol. 2020;14(1):39\u201346. https:\/\/doi.org\/10.1080\/17474124.2020.1708718.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"967_CR84","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1365-2036.2010.04409.x","volume":"32","author":"MA Adeyemo","year":"2010","unstructured":"Adeyemo MA, Spiegel BM, Chang L. Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? Aliment Pharmacol Ther. 2010;32(6):738\u201355. https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04409.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"22","key":"967_CR85","doi-asserted-by":"publisher","first-page":"6725","DOI":"10.3748\/wjg.v20.i22.6725","volume":"20","author":"M Meleine","year":"2014","unstructured":"Meleine M, Matricon J. Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones. World J Gastroenterol. 2014;20(22):6725\u201343. https:\/\/doi.org\/10.3748\/wjg.v20.i22.6725.","journal-title":"World J Gastroenterol"},{"issue":"7955","key":"967_CR86","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-023-05829-8","volume":"616","author":"JR Bayrer","year":"2023","unstructured":"Bayrer JR, Castro J, Venkataraman A, Touhara KK, Rossen ND, Morrie RD, et al. Gut enterochromaffin cells drive visceral pain and anxiety. Nature. 2023;616(7955):137\u201342. https:\/\/doi.org\/10.1038\/s41586-023-05829-8.","journal-title":"Nature"},{"issue":"12","key":"967_CR87","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nrn3360","volume":"13","author":"JS Mogil","year":"2012","unstructured":"Mogil JS. Sex differences in pain and pain inhibition: multiple explanations of a controversial phenomenon. Nat Rev Neurosci. 2012;13(12):859\u201366. https:\/\/doi.org\/10.1038\/nrn3360.","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"967_CR88","doi-asserted-by":"publisher","first-page":"558","DOI":"10.5056\/jnm16001","volume":"22","author":"MH Farzaei","year":"2016","unstructured":"Farzaei MH, Bahramsoltani R, Abdollahi M, Rahimi R. The role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatments. J Neurogastroenterol Motil. 2016;22(4):558\u201374. https:\/\/doi.org\/10.5056\/jnm16001.","journal-title":"J Neurogastroenterol Motil"},{"issue":"3","key":"967_CR89","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jpain.2012.11.008","volume":"14","author":"A Chaloner","year":"2013","unstructured":"Chaloner A, Greenwood-Van MB. Sexually dimorphic effects of unpredictable early life adversity on visceral pain behavior in a rodent model. J Pain. 2013;14(3):270\u201380. https:\/\/doi.org\/10.1016\/j.jpain.2012.11.008.","journal-title":"J Pain"},{"key":"967_CR90","doi-asserted-by":"publisher","unstructured":"Hubbard CS, Karpowicz JM, Furman AJ, da Silva JT, Seminowicz DA, Traub RJ. Estrogen-dependent visceral hypersensitivity following stress in rats: An fMRI study. Molecular pain. 2016;12:1744806916654145. https:\/\/doi.org\/10.1177\/1744806916654145.","DOI":"10.1177\/1744806916654145"},{"issue":"1","key":"967_CR91","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/nyas.13969","volume":"1428","author":"N Weltens","year":"2018","unstructured":"Weltens N, Iven J, Van Oudenhove L, Kano M. The gut-brain axis in health neuroscience: implications for functional gastrointestinal disorders and appetite regulation. Ann N Y Acad Sci. 2018;1428(1):129\u201350. https:\/\/doi.org\/10.1111\/nyas.13969.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"967_CR92","doi-asserted-by":"publisher","first-page":"415","DOI":"10.5056\/jnm16148","volume":"23","author":"A Guleria","year":"2017","unstructured":"Guleria A, Karyampudi A, Singh R, Khetrapal CL, Verma A, Ghoshal UC, et al. Mapping of brain activations to rectal balloon distension stimuli in male patients with irritable bowel syndrome using functional magnetic resonance imaging. J Neurogastroenterol Motil. 2017;23(3):415\u201327. https:\/\/doi.org\/10.5056\/jnm16148.","journal-title":"J Neurogastroenterol Motil"},{"issue":"11","key":"967_CR93","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1136\/gut.2003.028514","volume":"53","author":"CH Wilder-Smith","year":"2004","unstructured":"Wilder-Smith CH, Schindler D, Lovblad K, Redmond SM, Nirkko A. Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls. Gut. 2004;53(11):1595\u2013601. https:\/\/doi.org\/10.1136\/gut.2003.028514.","journal-title":"Gut"},{"issue":"6","key":"967_CR94","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/s0301-0082(02)00009-6","volume":"66","author":"MJ Millan","year":"2002","unstructured":"Millan MJ. Descending control of pain. Prog Neurobiol. 2002;66(6):355\u2013474. https:\/\/doi.org\/10.1016\/s0301-0082(02)00009-6.","journal-title":"Prog Neurobiol"},{"issue":"11","key":"967_CR95","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1111\/j.1526-4637.2010.00954.x","volume":"11","author":"Q Zhou","year":"2010","unstructured":"Zhou Q, Fillingim RB, Riley JL 3rd, Verne GN. Ischemic hypersensitivity in irritable bowel syndrome patients. Pain Med. 2010;11(11):1619\u201327. https:\/\/doi.org\/10.1111\/j.1526-4637.2010.00954.x.","journal-title":"Pain Med"},{"issue":"1","key":"967_CR96","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1053\/j.gastro.2009.09.054","volume":"138","author":"JH Winston","year":"2010","unstructured":"Winston JH, Xu GY, Sarna SK. Adrenergic stimulation mediates visceral hypersensitivity to colorectal distension following heterotypic chronic stress. Gastroenterology. 2010;138(1):294-304.e3. https:\/\/doi.org\/10.1053\/j.gastro.2009.09.054.","journal-title":"Gastroenterology"},{"issue":"46","key":"967_CR97","doi-asserted-by":"publisher","first-page":"7909","DOI":"10.3748\/wjg.v27.i46.7909","volume":"27","author":"HIR Magalh\u00e3es","year":"2021","unstructured":"Magalh\u00e3es HIR, Castelucci P. Enteric nervous system and inflammatory bowel diseases: Correlated impacts and therapeutic approaches through the P2X7 receptor. World J Gastroenterol. 2021;27(46):7909\u201324. https:\/\/doi.org\/10.3748\/wjg.v27.i46.7909.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"967_CR98","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1080\/14656566.2016.1182982","volume":"17","author":"E Scarpellini","year":"2016","unstructured":"Scarpellini E, Laterza L, Ianiro G, Tack J, Abenavoli L, Gasbarrini A. Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome. Expert Opin Pharmacother. 2016;17(10):1395\u2013402. https:\/\/doi.org\/10.1080\/14656566.2016.1182982.","journal-title":"Expert Opin Pharmacother"},{"key":"967_CR99","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.neuron.2022.11.015","volume":"111","author":"Z Xie","year":"2022","unstructured":"Xie Z, Feng J, Hibberd TJ, Chen B-N, Zhao Y, Zang K, et al. Piezo2 channels expressed by colon-innervating TRPV1-lineage neurons mediate visceral mechanical hypersensitivity. Neuron. 2022;111:526\u2013384.","journal-title":"Neuron"},{"key":"967_CR100","doi-asserted-by":"publisher","unstructured":"Xu J, McGinnis A, Ji R-RJN. Piezo2 mediates visceral mechanosensation: a new therapeutic target for gut pain? Neuron. 2023;111:450\u20132. https:\/\/doi.org\/10.1016\/j.neuron.2023.01.011.","DOI":"10.1016\/j.neuron.2023.01.011"},{"key":"967_CR101","doi-asserted-by":"publisher","first-page":"453","DOI":"10.5056\/jnm16114","volume":"23","author":"T Bai","year":"2017","unstructured":"Bai T, Li Y, Xia J, Jiang Y, Zhang L, Wang H, et al. Piezo2: A candidate biomarker for visceral hypersensitivity in irritable bowel syndrome? J Neurogastroenterol Motil. 2017;23:453\u201363.","journal-title":"J Neurogastroenterol Motil"},{"key":"967_CR102","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jcmgh.2021.12.012","volume":"13","author":"M Defaye","year":"2021","unstructured":"Defaye M, Abdullah N, Iftinca M, Hassan A, Agosti F, Zhang Z, et al. Gut-innervating TRPV1+ neurons drive chronic visceral pain via microglial P2Y12 receptor. Cell Mol Gastroenterol Hepatol. 2021;13:977\u201399.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"6","key":"967_CR103","doi-asserted-by":"publisher","first-page":"641","DOI":"10.12809\/hkmj177060","volume":"23","author":"JC Wu","year":"2017","unstructured":"Wu JC, Chan AO, Chan YW, Cheung GC, Cheung TK, Kwan AC, et al. The current treatment landscape of irritable bowel syndrome in adults in Hong Kong: consensus statements. Hong Kong Med J. 2017;23(6):641\u20137. https:\/\/doi.org\/10.12809\/hkmj177060.","journal-title":"Hong Kong Med J"},{"issue":"11","key":"967_CR104","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/jcm6110101","volume":"6","author":"M Camilleri","year":"2017","unstructured":"Camilleri M, Ford AC. Pharmacotherapy for irritable bowel syndrome. J Clin Med. 2017;6(11):101. https:\/\/doi.org\/10.3390\/jcm6110101.","journal-title":"J Clin Med"},{"issue":"1","key":"967_CR105","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","volume":"116","author":"BE Lacy","year":"2021","unstructured":"Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol. 2021;116(1):17\u201344. https:\/\/doi.org\/10.14309\/ajg.0000000000001036.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"967_CR106","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/apt.14519","volume":"47","author":"BP Chumpitazi","year":"2018","unstructured":"Chumpitazi BP, Kearns GL, Shulman RJ. Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders. Aliment Pharmacol Ther. 2018;47(6):738\u201352. https:\/\/doi.org\/10.1111\/apt.14519.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"967_CR107","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5056\/jnm15171","volume":"22","author":"K Bielefeldt","year":"2016","unstructured":"Bielefeldt K, Levinthal DJ, Nusrat S. Effective constipation treatment changes more than bowel frequency: a systematic review and meta-analysis. J Neurogastroenterol Motil. 2016;22(1):31\u201345. https:\/\/doi.org\/10.5056\/jnm15171.","journal-title":"J Neurogastroenterol Motil"},{"issue":"4","key":"967_CR108","doi-asserted-by":"publisher","first-page":"e682","DOI":"10.1016\/j.cgh.2021.05.040","volume":"20","author":"BE Lacy","year":"2022","unstructured":"Lacy BE, Brenner DM, Chey WD. Re-evaluation of the cardiovascular safety profile of tegaserod: a review of the clinical data. Clin Gastroenterol Hepatol. 2022;20(4):e682\u201395. https:\/\/doi.org\/10.1016\/j.cgh.2021.05.040.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"967_CR109","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.cgh.2019.07.007","volume":"18","author":"CJ Black","year":"2020","unstructured":"Black CJ, Burr NE, Ford AC. Relative efficacy of tegaserod in a systematic review and network meta-analysis of licensed therapies for irritable bowel syndrome with constipation. Clin Gastroenterol Hepatol. 2020;18(5):1238-9.e1. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.007.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"967_CR110","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1177\/1756283x17734809","volume":"10","author":"A Omer","year":"2017","unstructured":"Omer A, Quigley EMM. An update on prucalopride in the treatment of chronic constipation. Therap Adv Gastroenterol. 2017;10(11):877\u201387. https:\/\/doi.org\/10.1177\/1756283x17734809.","journal-title":"Therap Adv Gastroenterol"},{"issue":"2","key":"967_CR111","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.tips.2021.11.002","volume":"43","author":"SM Brierley","year":"2022","unstructured":"Brierley SM, Grundy L, Castro J, Harrington AM, Hannig G, Camilleri M. Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain. Trends Pharmacol Sci. 2022;43(2):110\u201322. https:\/\/doi.org\/10.1016\/j.tips.2021.11.002.","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"967_CR112","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/ajg.2017.495","volume":"113","author":"ED Shah","year":"2018","unstructured":"Shah ED, Kim HM, Schoenfeld P. Efficacy and tolerability of guanylate cyclase-c agonists for irritable bowel syndrome with constipation and chronic idiopathic constipation: a systematic review and meta-analysis. Am J Gastroenterol. 2018;113(3):329\u201338. https:\/\/doi.org\/10.1038\/ajg.2017.495.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"967_CR113","doi-asserted-by":"publisher","first-page":"e000094","DOI":"10.1136\/bmjgast-2016-000094","volume":"3","author":"I Sonu","year":"2016","unstructured":"Sonu I, Triadafilopoulos G, Gardner JD. Persistent constipation and abdominal adverse events with newer treatments for constipation. BMJ Open Gastroenterol. 2016;3(1):e000094. https:\/\/doi.org\/10.1136\/bmjgast-2016-000094.","journal-title":"BMJ Open Gastroenterol"},{"issue":"6","key":"967_CR114","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.14309\/ajg.0000000000001056","volume":"116","author":"WD Chey","year":"2021","unstructured":"Chey WD, Lembo AJ, Yang Y, Rosenbaum DP. Efficacy of tenapanor in treating patients with irritable bowel syndrome with constipation: A 26-Week, placebo-controlled phase 3 trial (T3MPO-2). Am J Gastroenterol. 2021;116(6):1294\u2013303. https:\/\/doi.org\/10.14309\/ajg.0000000000001056.","journal-title":"Am J Gastroenterol"},{"issue":"17","key":"967_CR115","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/s40265-021-01634-7","volume":"81","author":"EV Wechsler","year":"2021","unstructured":"Wechsler EV, Shah ED. Diarrhea-predominant and constipation-predominant irritable bowel syndrome: current prescription drug treatment options. Drugs. 2021;81(17):1953\u201368. https:\/\/doi.org\/10.1007\/s40265-021-01634-7.","journal-title":"Drugs"},{"issue":"11","key":"967_CR116","doi-asserted-by":"publisher","first-page":"e14658","DOI":"10.1111\/nmo.14658","volume":"35","author":"AJ Lembo","year":"2023","unstructured":"Lembo AJ, Friedenberg KA, Fogel RP, Edelstein S, Zhao S, Yang Y, et al. Long-term safety of tenapanor in patients with irritable bowel syndrome with constipation in the T3MPO-3 study. Neurogastroenterol Motil. 2023;35(11):e14658. https:\/\/doi.org\/10.1111\/nmo.14658.","journal-title":"Neurogastroenterol Motil"},{"issue":"4","key":"967_CR117","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/01.mcg.0000225665.68920.df","volume":"41","author":"BE Lacy","year":"2007","unstructured":"Lacy BE, Levy LC. Lubiprostone: a chloride channel activator. J Clin Gastroenterol. 2007;41(4):345\u201351. https:\/\/doi.org\/10.1097\/01.mcg.0000225665.68920.df.","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"967_CR118","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.mayocp.2016.01.015","volume":"91","author":"F Li","year":"2016","unstructured":"Li F, Fu T, Tong WD, Liu BH, Li CX, Gao Y, et al. Lubiprostone is effective in the treatment of chronic idiopathic constipation and irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc. 2016;91(4):456\u201368. https:\/\/doi.org\/10.1016\/j.mayocp.2016.01.015.","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"967_CR119","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1007\/s10620-017-4680-1","volume":"62","author":"B Cryer","year":"2017","unstructured":"Cryer B, Drossman DA, Chey WD, Webster L, Habibi S, Wang M. Analysis of nausea in clinical studies of lubiprostone for the treatment of constipation disorders. Dig Dis Sci. 2017;62(12):3568\u201378. https:\/\/doi.org\/10.1007\/s10620-017-4680-1.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"967_CR120","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41395-018-0222-5","volume":"114","author":"AC Ford","year":"2019","unstructured":"Ford AC, Lacy BE, Harris LA, Quigley EMM, Moayyedi P. Effect of antidepressants and psychological therapies in irritable bowel syndrome: an updated systematic review and meta-analysis. Am J Gastroenterol. 2019;114(1):21\u201339. https:\/\/doi.org\/10.1038\/s41395-018-0222-5.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"967_CR121","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1365-2036.2005.02566.x","volume":"22","author":"H Vahedi","year":"2005","unstructured":"Vahedi H, Merat S, Rashidioon A, Ghoddoosi A, Malekzadeh R. The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study. Aliment Pharmacol Ther. 2005;22(5):381\u20135. https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02566.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"967_CR122","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/apt.15001","volume":"48","author":"AC Ford","year":"2018","unstructured":"Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther. 2018;48(10):1044\u201360. https:\/\/doi.org\/10.1111\/apt.15001.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"967_CR123","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.3748\/wjg.v20.i7.1871","volume":"20","author":"GQ Chao","year":"2014","unstructured":"Chao GQ, Zhang S. Effectiveness of acupuncture to treat irritable bowel syndrome: a meta-analysis. World J Gastroenterol. 2014;20(7):1871\u20137. https:\/\/doi.org\/10.3748\/wjg.v20.i7.1871.","journal-title":"World J Gastroenterol"},{"key":"967_CR124","doi-asserted-by":"publisher","first-page":"694741","DOI":"10.3389\/fphar.2021.694741","volume":"12","author":"H Zheng","year":"2021","unstructured":"Zheng H, Jin S, Shen YL, Peng WY, Ye K, Tang TC, et al. Chinese herbal medicine for irritable bowel syndrome: a meta-analysis and trial sequential analysis of randomized controlled trials. Front Pharmacol. 2021;12:694741. https:\/\/doi.org\/10.3389\/fphar.2021.694741.","journal-title":"Front Pharmacol"},{"key":"967_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2881-9","author":"I Vujkovic-Cvijin","year":"2020","unstructured":"Vujkovic-Cvijin I, Sklar J, Jiang L, Natarajan L, Knight R, Belkaid Y. Host variables confound gut microbiota studies of human disease. Nature. 2020. https:\/\/doi.org\/10.1038\/s41586-020-2881-9.","journal-title":"Nature"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-025-00967-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-025-00967-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-025-00967-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T11:04:16Z","timestamp":1772535856000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-025-00967-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["967"],"URL":"https:\/\/doi.org\/10.1007\/s11894-025-00967-7","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"12 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The preparation of this manuscript was supported by funding from Health@InnoHK Initiative Fund of the Hong Kong Special Administrative Region Government (ITC RC\/IHK\/4\/7) and Vincent and Lily Woo Foundation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial Support"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"22"}}